Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Avicanna (DE:0NN)
FRANKFURT:0NN
Avicanna (0NN) Stock Price & Analysis
0 Followers
0NN Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€0.16 - €0.38
Previous Close€0.23
Volume0.00
Average Volume (3M)2.30K
Market Cap
€21.56M
Enterprise Value€25.20M
Total Cash (Recent Filing)C$718.29K
Total Debt (Recent Filing)C$2.13M
Price to Earnings (P/E)N/A
Beta1.35
Next Earnings
May 27, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding87,687,800
10 Day Avg. Volume0
30 Day Avg. Volume2,300
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)-51.48
Price to Sales (P/S)4.90
Price to Cash Flow (P/CF)N/A
P/FCF Ratio92.80
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Avicanna News
PremiumCompany Announcements
Avicanna Secures Funding to Fuel Growth
PremiumCompany Announcements
Avicanna’s Gel Shows Promise for Pain Relief
PremiumCompany Announcements
Avicanna Inc. Celebrates Soaring 2023 Profits
PremiumCompany Announcements
Avicanna Releases New CBD Formulation in CanadaOptions Prices
Currently, No data available
---
Ownership Overview
0.00% Insiders
0.00% Mutual Funds
0.01% Other Institutional Investors
99.99% Public Companies and
Individual Investors
0NN FAQ
What was Avicanna’s price range in the past 12 months?
Avicanna lowest stock price was €0.16 and its highest was €0.38 in the past 12 months.
What is Avicanna’s market cap?
Currently, no data Available
When is Avicanna’s upcoming earnings report date?
Avicanna’s upcoming earnings report date is May 27, 2024 which is in 27 days.
How were Avicanna’s earnings last quarter?
Avicanna released its earnings results on Apr 02, 2024. The company reported -€0.019 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.019.
Is Avicanna overvalued?
According to Wall Street analysts Avicanna’s price is currently Overvalued.
Does Avicanna pay dividends?
Avicanna does not currently pay dividends.
What is Avicanna’s EPS estimate?
Avicanna’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Avicanna have?
Currently, no data Available
What happened to Avicanna’s price movement after its last earnings report?
Avicanna reported an EPS of -€0.019 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -2.924%.
Which hedge fund is a major shareholder of Avicanna?
Currently, no hedge funds are holding shares in DE:0NN
---
Avicanna Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
3.51%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
28.14%
Trailing 12-Months
Company Description
Avicanna
Avicanna is an Ontario corporation focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products via its two main business segments, cultivation and R&D With two majority-owned subsidiaries, Sativa Nativa S.A.S. and Santa Marta Golden Hemp S.A.S., both located in Santa Marta, Colombia are the base for Avicanna's cultivation activities. These companies are licensed to cultivate and process cannabis for the production of cannabis extracts and purified cannabinoids including CBD and THC. Avicanna's research and development business is primarily conducted out of Canada at its headquarters in the Johnson & Johnson Innovation Centre, JLABS @ Toronto. Avicanna has engaged the services of researchers at the Leslie Dan Faculty of Pharmacy at the University of Toronto.
---
0NN Earnings Call
Q4 2024
0:00 / 0:00
---
Technical Analysis
---